REFERENCES
Robinson DS, Roberts DL, Smith JM, Stringfellow JC, Kaplita SB, Seminara JA, Marcus RN: The safety profile of nefazodone. J Clin Psychiatry 57(suppl 2):31-38, 1996
Sharpley AL, Walsh AE, Cowen PJ: Nefazodone-a novel antidepressant-may increase REM sleep. Biol Psychiatry 31:1070-1073, 1992
Taylor DP, Carter RB, Eison AS, Mullins UL, Smith HL, Torrente JR, Wright RN, Yocca FD: Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug. J Clin Psychiatry 56(suppl 6):3-11, 1995
Aranda-Michel J, Koehler A, Bejarano PA, Poulos JE, Luxon BA, Khan CM, Ee LC, Balistreri WF, Weber FL: Nefazodone-induced liver failure: Report of three cases. Ann Intern Med 130:285-288, 1999
Stricker BH, Blok AP, Claas FH, Van PE, Desmet VJ: Hepatic injury associated with the use of nitrofurans: A clinicopathological study of 52 reported cases. Hepatology 8:599-606, 1988
Reinhart HH, Reinhart E, Korlipara P, Peleman R: Combined nitrofurantoin toxicity to liver and lung. Gastroenterology 102:1396-1399, 1992
Kelly BD, Heneghan MA, Bennani F, Connolly CE, O'Gorman TA: Nitrofurantoin-induced hepatotoxicity mediated by CD8+ T cells. Am J Gastroenterol 93:819-821, 1998
Barbhaiya RH, Shukla UA, Natarajan CS, Behr DA, Greene DS, Sainati SM: Single-and multiple-dose pharmacokinetics of nefazodone in patients with hepatic cirrhosis. Clin Pharmacol Ther 58:390-398, 1995
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eloubeidi, M.A., Gaede, J.T. & Swaim, M.W. Case Report: Reversible Nefazodone-Induced Liver Failure. Dig Dis Sci 45, 1036–1038 (2000). https://doi.org/10.1023/A:1005558015787
Issue Date:
DOI: https://doi.org/10.1023/A:1005558015787